» Articles » PMID: 36035221

TRIM65 Promotes Malignant Cell Behaviors in Triple-Negative Breast Cancer by Impairing the Stability of LATS1 Protein

Overview
Publisher Wiley
Date 2022 Aug 29
PMID 36035221
Authors
Affiliations
Soon will be listed here.
Abstract

TNBC is a malignant tumor that easily relapses and metastasizes, with a poor prognosis in women. Ubiquitination plays a key role in promoting the tumor process. In various tumors, TRIM65 can affect malignant biological tumor behavior by ubiquitination of related proteins. We aimed to investigate TRIM65 expression in TNBC and whether it promotes malignant biological behavior in TNBC cells using Cell Counting Kit-8, colony formation, and transwell assays. Mechanically, we confirmed that TRIM65 promoted TNBC invasion and metastasis by ubiquitination of LATS1 protein through Co-IP, CHX, and endogenous ubiquitination experiments. The expression of TRIM65 was abnormally high and accelerated the proliferation, invasion, and migration of MDA-MB-231 and MDA-MB-453 cells. animal experiments also revealed that TRIM65 accelerated TNBC cell proliferation. Mechanistically, TRIM65 degraded LATS1 protein expression through ubiquitination in the Co-IP, CHX, and endogenous ubiquitination experiments. Rescue assays confirmed that TRIM65 degraded LATS1 protein expression, accelerating the proliferation, invasion, and migration ability of TNBC cells. Our results show that TRIM65 is upregulated in TNBC, and TRIM65 degrades LATS1 protein expression through ubiquitination and promotes malignant biological behavior in TNBC cells. TRIM65 may play an important role as a new oncogene in TNBC.

Citing Articles

Cancer-associated fibroblasts affect breast cancer cell sensitivity to chemotherapeutic agents by regulating NRBP2.

Jin X, Chen Y, Wang G Toxicol Res (Camb). 2024; 13(6):tfae204.

PMID: 39664500 PMC: 11631068. DOI: 10.1093/toxres/tfae204.


Addressing the mean-variance relationship in spatially resolved transcriptomics data with .

Shah K, Guo B, Hicks S bioRxiv. 2024; .

PMID: 39574747 PMC: 11580860. DOI: 10.1101/2024.11.04.621867.


Multifaceted role of in health and disease.

Maghsoudloo M, Mokhtari K, Jamali B, Gholamzad A, Entezari M, Hashemi M MedComm (2020). 2024; 5(11):e790.

PMID: 39534556 PMC: 11554878. DOI: 10.1002/mco2.790.


TRIM65/NF2/YAP1 Signaling Coordinately Orchestrates Metabolic and Immune Advantages in Hepatocellular Carcinoma.

Bian Z, Xu C, Wang X, Zhang B, Xiao Y, Liu L Adv Sci (Weinh). 2024; 11(35):e2402578.

PMID: 39005234 PMC: 11425264. DOI: 10.1002/advs.202402578.


TRIM65 deficiency alleviates renal fibrosis through NUDT21-mediated alternative polyadenylation.

Wei S, Huang X, Zhu Q, Chen T, Zhang Y, Tian J Cell Death Differ. 2024; 31(11):1422-1438.

PMID: 38951701 PMC: 11519343. DOI: 10.1038/s41418-024-01336-z.


References
1.
Jia J, Jin J, Chen Q, Yuan Z, Li H, Bian J . Eukaryotic expression, Co-IP and MS identify BMPR-1B protein-protein interaction network. Biol Res. 2020; 53(1):24. PMC: 7257232. DOI: 10.1186/s40659-020-00290-7. View

2.
Tang T, Li P, Zhou X, Wang R, Fan X, Yang M . The E3 Ubiquitin Ligase TRIM65 Negatively Regulates Inflammasome Activation Through Promoting Ubiquitination of NLRP3. Front Immunol. 2021; 12:741839. PMC: 8427430. DOI: 10.3389/fimmu.2021.741839. View

3.
Fornage M, Debette S, Bis J, Schmidt H, Ikram M, Dufouil C . Genome-wide association studies of cerebral white matter lesion burden: the CHARGE consortium. Ann Neurol. 2011; 69(6):928-39. PMC: 3122147. DOI: 10.1002/ana.22403. View

4.
Meroni G, Desagher S . Cellular Function of TRIM E3 Ubiquitin Ligases in Health and Disease. Cells. 2022; 11(2). PMC: 8773487. DOI: 10.3390/cells11020250. View

5.
Hu G, Liu N, Wang H, Wang Y, Guo Z . LncRNA LINC01857 promotes growth, migration, and invasion of glioma by modulating miR-1281/TRIM65 axis. J Cell Physiol. 2019; 234(12):22009-22016. DOI: 10.1002/jcp.28763. View